Kim Oreskovic is a seasoned healthcare and life sciences executive with a background in corporate finance, venture capital, and strategic advisory in diagnostics and healthtech.
She has held senior advisory roles with MDxHealth, Agendia, and IBL—successfully sold to Tecan—and began her career at KPMG in corporate advisory. She was General Partner at Antler, focusing on early-stage healthcare and technology investments, and is the founder of Innoviance, an advisory and investment platform supporting healthcare innovation. She has also advised SPDG, the D’Ieteren Group Family Office.
A Chartered Accountant, Kim brings deep expertise in strategy, investment, and corporate transformation, combining financial rigor with a strong track record in complex transactions and scaling innovative health technologies globally.
LinkedIn